Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Elizabeth Weihe"'
Autor:
Rebecca A. Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B. Schwab, Emily I. Pittman, Minya Pu, Elizabeth Weihe, Emanuela M. Ghia, Laura Z. Rassenti, Alfredo Molinolo, Betty Cabrera, James B. Breitmeyer, George F. Widhopf, Karen Messer, Catriona Jamieson, Thomas J. Kipps, Barbara A. Parker
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Background Zilovertamab is a humanized monoclonal antibody targeting ROR1, an onco-embryonic antigen expressed by malignant cells of a variety of solid tumors, including breast cancer. A prior phase 1 study showed that zilovertamab was well
Externí odkaz:
https://doaj.org/article/0486bdf60d074a82b6fba59959ed172b
Autor:
Rebecca A. Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B. Schwab, Emily I. Pittman, Minya Pu, Elizabeth Weihe, Emanuela M. Ghia, Laura Z. Rassenti, Alfredo Molinolo, Betty Cabrera, James B. Breitmeyer, George F. Widhopf II, Karen Messer, Catriona Jamieson, Thomas J. Kipps, Barbara A. Parker
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/e6112c11579145ef905f2712d4ff134a
Autor:
Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Scott M. Lippman, Jason K. Sicklick, Razelle Kurzrock
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
A molecular tumor board (MTB) is often used as a platform that integrates clinical and molecular parameters for clinical decision making. Here, the authors review the outcome of 715 cancer patients presented at their institution’s MTB, and demonstr
Externí odkaz:
https://doaj.org/article/be2daa0bb1884adbb304041e571d8edf
Autor:
Kripa Guram, Maria Nunez, John Einck, Loren K. Mell, Ezra Cohen, P. Dominick Sanders, Sayuri Miyauchi, Elizabeth Weihe, Razelle Kurzrock, Sarah Boles, Andrew B. Sharabi
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: Undifferentiated pleomorphic sarcoma (UPS) of the maxillary sinus is an extremely rare malignancy of the head and neck. Surgery is the mainstay of treatment for UPS; however, proximity to vital structures makes it challenging to achieve n
Externí odkaz:
https://doaj.org/article/f7a85e3677fe4238a957b53f4c547a70
Autor:
Razelle Kurzrock, Scott M. Lippman, Ezra Cohen, Mark G. Erlander, Muneesh Tewari, Ben Ho Park, Elizabeth Weihe, Sandeep C. Pingle, Soham More, Brian Woodward, Karena Kosco, Vladislava O. Melnikova, Hatim Husain
Urine volumes, DNA concentrations, DNA input amounts, the number of output mutant sequencing reads, mutant copies detected and the 95% Confidence Intervals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eccccc0fdd08ef10d8be0927574bd3b
https://doi.org/10.1158/1078-0432.22462269
https://doi.org/10.1158/1078-0432.22462269
Autor:
Razelle Kurzrock, Scott M. Lippman, Ezra Cohen, Mark G. Erlander, Muneesh Tewari, Ben Ho Park, Elizabeth Weihe, Sandeep C. Pingle, Soham More, Brian Woodward, Karena Kosco, Vladislava O. Melnikova, Hatim Husain
Purpose: Noninvasive drug biomarkers for the early assessment of tumor response can enable adaptive therapeutic decision-making and proof-of-concept studies for investigational drugs. Circulating tumor DNA (ctDNA) is released into the circulation by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc7793225b3554c9474da72c95207d2
https://doi.org/10.1158/1078-0432.c.6525063.v1
https://doi.org/10.1158/1078-0432.c.6525063.v1
Autor:
Razelle Kurzrock, Scott M. Lippman, Ezra Cohen, Mark G. Erlander, Muneesh Tewari, Ben Ho Park, Elizabeth Weihe, Sandeep C. Pingle, Soham More, Brian Woodward, Karena Kosco, Vladislava O. Melnikova, Hatim Husain
A: Analysis of dilution series of indicated mutant EGFR variants spiked into 60 ng (â‰^18,180 genome equivalents) of WT DNA. Each data point represents one preparative within 6 independent dilutions series prepared and analyzed by two operators on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dddddf20c6822c45764e46cd43fc8630
https://doi.org/10.1158/1078-0432.22462272.v1
https://doi.org/10.1158/1078-0432.22462272.v1
Autor:
Hatim Husain, Victor E. Velculescu, Robert B. Scharpf, Valsamo Anagnostou, Elizabeth Weihe, Vilmos Adleff, Parissa Keshavarzian, Daniel C. Bruhm, Christopher D. Gocke, Doreen N. Palsgrove, Stephen Cristiano, Jamie E. Medina, Jacob Fiksel, Julie R. Brahmer, Kristen A. Marrone, Jarushka Naidoo, Patrick M. Forde, Brian D. Woodward, Alessandro Leal, Jillian Phallen
The supplementary tables for "Early noninvasive detection of response to targeted therapy in non-small cell lung cancer" report clinical characteristics of patients analyzed (1), serial timepoints analyzed (2), genes analyzed (3), a summary of genomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba01d05eb1651648d31488dbb700b8b
https://doi.org/10.1158/0008-5472.22423020.v1
https://doi.org/10.1158/0008-5472.22423020.v1
Autor:
Hatim Husain, Victor E. Velculescu, Robert B. Scharpf, Valsamo Anagnostou, Elizabeth Weihe, Vilmos Adleff, Parissa Keshavarzian, Daniel C. Bruhm, Christopher D. Gocke, Doreen N. Palsgrove, Stephen Cristiano, Jamie E. Medina, Jacob Fiksel, Julie R. Brahmer, Kristen A. Marrone, Jarushka Naidoo, Patrick M. Forde, Brian D. Woodward, Alessandro Leal, Jillian Phallen
The supplementary figures for "Early noninvasive detection of response to targeted therapy in non-small cell lung cancer" depict dynamic changes of ctDNA during therapy (S1), copy number changes identified in cfDNA from analyses of whole-genome data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6817dc7ca991b8fea9af1673d31b89
https://doi.org/10.1158/0008-5472.22423023
https://doi.org/10.1158/0008-5472.22423023
Autor:
Hatim Husain, Victor E. Velculescu, Robert B. Scharpf, Valsamo Anagnostou, Elizabeth Weihe, Vilmos Adleff, Parissa Keshavarzian, Daniel C. Bruhm, Christopher D. Gocke, Doreen N. Palsgrove, Stephen Cristiano, Jamie E. Medina, Jacob Fiksel, Julie R. Brahmer, Kristen A. Marrone, Jarushka Naidoo, Patrick M. Forde, Brian D. Woodward, Alessandro Leal, Jillian Phallen
With the advent of precision oncology, there is an urgent need to develop improved methods for rapidly detecting responses to targeted therapies. Here, we have developed an ultrasensitive measure of cell-free tumor load using targeted and whole-genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d54fa3cd9918bcb36f5fd2b1ef4222c2
https://doi.org/10.1158/0008-5472.c.6511401.v1
https://doi.org/10.1158/0008-5472.c.6511401.v1